FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

American Health Packaging Mercaptopurine Tablets Recall

Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton,…

American Health Packaging · Columbus, OH

Risk level
Class II
Reported by FDA
Dec 24, 2014
Recall ID
D-0300-2015
Check your lot numberHow we source this data

Summary

American Health Packaging recalled Mercaptopurine Tablets starting Nov 19, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0300-2015 on Dec 24, 2014. Reason: Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution. Status: Terminated.

Why it was recalled

Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.

Product description

Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, Manufactured by Prometheus Laboratories Inc. 9410 Carroll Park Drive, San Diego, CA 92121, repackaged by American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217, NDC 68084-325-21

Lot numbers, UPCs & expiration codes

Lot #: 142450 Exp 05/2015; 140862 Exp 02/2015; 141596 Exp 03/2015; 134770 Exp 01/2015

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0300-2015
Classification
Class II
Status
Terminated
Recall initiated
Nov 19, 2014
FDA report date
Dec 24, 2014
Quantity
3496 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
American Health Packaging

Original FDA data

Every field from FDA enforcement report D-0300-2015, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
69972
Address
2550 John Glenn Ave
Address (line 2)
Suite A
Code information
Lot #: 142450 Exp 05/2015; 140862 Exp 02/2015; 141596 Exp 03/2015; 134770 Exp 01/2015
Postal code
43217-1188
Report date
Dec 24, 2014
Product type
Drugs
Recall number
D-0300-2015
Classification
Class II
Recalling firm
American Health Packaging
Product quantity
3496 cartons
Termination date
Jun 1, 2015
Reason for recall
Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, Manufactured by Prometheus Laboratories Inc. 9410 Carroll Park Drive, San Diego, CA 92121, repackaged by American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217, NDC 68084-325-21
Distribution pattern
Nationwide.
Recall initiation date
Nov 19, 2014
Initial firm notification
Letter
Center classification date
Dec 16, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0300-2015, published Dec 24, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls